Service
Custom proteins on demand—designed, expressed, and delivered using AI and synthetic biology for research, diagnostics, or industry.
- Research & Development
Startup / Scaleup
biolinker.tech/Cotia, BrazilBioLinker is a São Paulo‑based synthetic biology powerhouse, engineering next‑generation proteins via AI-driven platforms. As the first Latin American company to provide cell‑free systems for complex protein expression, BioLinker serves Fortune 500 clients and specializes in hard‑to‑express proteins for pharma, agriculture, diagnostics, and industrial biotech. Website
Their proprietary Sol platform offers modular, scalable protein engineering—blending in‑silico design, cell‑free and cell‑based systems, directed evolution, and purification pipelines.
In 2022, BioLinker gained recognition for developing a rapid SARS‑CoV‑2 self‑test—producing all reagents locally in São Paulo, supported by FAPESP’s PIPE program, with 15‑minute home results across all variants agencia.fapesp.br.
The company has also been featured at scientific article at PubMed as recent publication Antigen
Awards & recognition:
Top 500 DeepTech Startup (Hello Tomorrow)
Top 3 Biotech Startup in Brazil (100 Open Startups)
Sebrae “Startup of the Future”
Top 40 at Wolves Summit
USP Alumni Award for Innovation & Entrepreneurship .
Services
Advanced manufacturing technologies
Industry
Industry 4.0
Manufacturing
Service
Custom proteins on demand—designed, expressed, and delivered using AI and synthetic biology for research, diagnostics, or industry.
Product
InvitroLinker boosts swine sperm viability by up to 70%—a protein-based additive for more efficient artificial insemination.
Investment
BioLinker seeks seed investment to scale its synbio platform and launch high-impact biotech solutions like InvitroLinker.